Area Business Manager- Boston

Boston, Massachusetts, United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess strong clinical and business acumen, with a deep understanding of analytics to identify business opportunities and create actionable business plans. Existing relationships with local Endocrinologist HCPs and working knowledge of market access and local impacts on territory-level business trends are strongly preferred. The role requires the ability to display a high level of clinical and business acumen and accountability for self to demonstrate mastery level of clinical knowledge, including assessments.

Responsibilities

The Area Business Manager will develop territory business plans to achieve sales goals, build relationships with healthcare professionals, and drive product adoption. Responsibilities include effectively communicating the clinical profile of Resmetirom, evaluating office readiness for patient identification and prescribing, providing education on market access and fulfillment processes, and ensuring compliant pull-through of prescriptions. The ABM will also execute promotional and disease state education programs, strategically plan and prioritize sales activities, analyze sales data and market trends, and provide in-depth product training to healthcare professionals and their staff.

Skills

Sales

Business Planning

Healthcare Professional (HCP) Relationship Building

Product Adoption

Analytics

Market Access

Endocrinology

Biopharmaceutical Sales

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free